In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

被引:133
作者
Shin, T
Yoshimura, K
Shin, T
Crafton, EB
Tsuchiya, H
Housseau, F
Koseki, H
Schulick, RD
Chen, LP
Pardoll, DM [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA
[3] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan
关键词
D O I
10.1084/jem.20050072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B7-DC, one of the recently described B7 family members, has the capacity to inhibit T cell responses via engagement of the immunoreceptor tyrosine-based inhibitory motif-containing inhibitory PD-1 receptor as well as enhance responses via an as yet unidentified costimulatory receptor. B7-DC is highly homologous to a coinhibitory B7 family member, B7-H1, which also binds PD-1. It is currently unclear which B7-DC function-costimulation or inhibition predominates in vivo. To study in vivo functions of B7-DC, we evaluated immune responses in B7-DC knockout (KO) mice. Although not eliminated, interferon-gamma (IFN-gamma) production by CD4 T cells and IFN-gamma-dependent humoral responses were reduced in B7-DC KO mice relative to wild type mice. Antigen-specific CD8 T cell responses and cytotoxic T lymphocyte (CTL) activity were also diminished in B7-DC KO mice. Hepatic tumors grew more quickly in B7-DC KO mice, associated with a decrease in intrahepatic tumor-specific CD8 T cells. These results highlight the contrasting in vivo roles of B7-DC and B7-H1 and indicate that B7-DC functions as a tuning molecule, selectively augmenting T helper 1 and CTL responses.
引用
收藏
页码:1531 / 1541
页数:11
相关论文
共 35 条
  • [31] A novel transcription factor, T-bet, directs Th1 lineage commitment
    Szabo, SJ
    Kim, ST
    Costa, GL
    Zhang, XK
    Fathman, CG
    Glimcher, LH
    [J]. CELL, 2000, 100 (06) : 655 - 669
  • [32] B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
    Tseng, SY
    Otsuji, M
    Gorski, K
    Huang, X
    Slansky, JE
    Pai, SI
    Shalabi, A
    Shin, T
    Pardoll, DM
    Tsuchiya, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (07) : 839 - 845
  • [33] Components of difference in HIV seropositivity rate among injection drug users between low- and high-HIV-prevalence regions
    Wang, JC
    [J]. AIDS AND BEHAVIOR, 2003, 7 (01) : 1 - 8
  • [34] BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
    Watanabe, N
    Gavrieli, M
    Sedy, JR
    Yang, JF
    Fallarino, F
    Loftin, SK
    Hurchla, MA
    Zimmerman, N
    Sim, J
    Zang, XX
    Murphy, TL
    Russell, JH
    Allison, JP
    Murphy, KM
    [J]. NATURE IMMUNOLOGY, 2003, 4 (07) : 670 - 679
  • [35] Estimation of the lowest triplet π,π* energy level of 1,4-tetracenequinone by use of triplet energy transfer in solution
    Yamaji, M
    Takahashi, K
    Itoh, T
    Tobita, S
    [J]. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2002, 1 (03) : 169 - 171